Vascular Biogenics Probability of Future Stock Price Finishing Over 0.24
| VBLTDelisted Stock | USD 0.28 0.01 3.45% |
Vascular |
Vascular Biogenics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vascular Biogenics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vascular Biogenics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Vascular Biogenics is not yet fully synchronised with the market data | |
| Vascular Biogenics has some characteristics of a very speculative penny stock | |
| Vascular Biogenics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 658 K. Net Loss for the year was (32.3 M) with profit before overhead, payroll, taxes, and interest of 554 K. | |
| Vascular Biogenics currently holds about 34.15 M in cash with (31.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 13.0% of the company outstanding shares are owned by insiders |
Vascular Biogenics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vascular Stock often depends not only on the future outlook of the current and potential Vascular Biogenics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vascular Biogenics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 77.6 M | |
| Cash And Short Term Investments | 20.7 M |
Vascular Biogenics Technical Analysis
Vascular Biogenics' future price can be derived by breaking down and analyzing its technical indicators over time. Vascular Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vascular Biogenics. In general, you should focus on analyzing Vascular Stock price patterns and their correlations with different microeconomic environments and drivers.
Vascular Biogenics Predictive Forecast Models
Vascular Biogenics' time-series forecasting models is one of many Vascular Biogenics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vascular Biogenics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Vascular Biogenics
Checking the ongoing alerts about Vascular Biogenics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vascular Biogenics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Vascular Biogenics is not yet fully synchronised with the market data | |
| Vascular Biogenics has some characteristics of a very speculative penny stock | |
| Vascular Biogenics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 658 K. Net Loss for the year was (32.3 M) with profit before overhead, payroll, taxes, and interest of 554 K. | |
| Vascular Biogenics currently holds about 34.15 M in cash with (31.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 13.0% of the company outstanding shares are owned by insiders |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |